LONDON BROKER RATINGS: RBC raises B&M European Value to sector perform
LONDON BROKER RATINGS: RBC raises B&M European Value to sector perform
Read moreLONDON BROKER RATINGS: RBC raises B&M European Value to sector perform
Read moreLONDON BROKER RATINGS: Barclays lifts ITV and S4 Capital to Overweight
Read moreSmith & Nephew acquires US partial knee system company Engage Surgical
Read moreLONDON BROKER RATINGS: Goldman Sachs raises BT to Conviction Buy
Read more(Sharecast News) - Analysts at Berenberg raised their target price on medical services firm Smith & Nephew from £18.25 to £18.40 on Friday following the firm's "extensive meet-the-management event" a day earlier.
Read moreLONDON BROKER RATINGS: Trio of cuts for boohoo; Liberum lifts Domino's
Read moreIN BRIEF: Smith & Nephew to return up to USD300 million to investors
Read more(Sharecast News) - Medical device maker Smith & Nephew outlined its new 'strategy for growth' on Thursday, targeting consistent 4% to 6% organic revenue growth by 2024, "structurally ahead" of historic levels, as it made a new commitment to return up to $300m of capital to shareholders.
Read moreLloyds, Anglo American and slimmer Tate & Lyle set for strong 2022
Read moreLONDON BROKER RATINGS: StanChart and Flutter upped to Buy; THG cut
Read moreLONDON MARKET MIDDAY: Pound drops, stocks rise after BoE holds rates
Read moreTOP NEWS: Smith & Nephew to hit low end of 2021 financial guidance
Read moreLONDON MARKET PRE-OPEN: BT revenue slips but reinstates dividend
Read more(Sharecast News) - Smith & Nephew warned annual results would be at the low end of its guidance after Covid-19 and product shortages affected its orthopaedics business in the third quarter.
Read moreUK earnings, trading statements calendar - next 7 days
Read more